GlassScriptPhysician profile
Whitney Jolitz
NPI 1407269053
$881.11
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $550 · 2020: $219 · 2021: $59.62 · 2022: $19.02 · 2023: $16.31 · 2024: $17.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $33.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $33.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $231.32 | 2019-2020 | |
| Abbvie INC. | $208.35 | 2019-2021 | |
| Therapeuticsmd, INC. | $119.98 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $87.06 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $55.12 | 2019-2020 | |
| Astellas Pharma US INC | $32.85 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.79 | 2019 | |
| Myovant Sciences INC. | $19.69 | 2021 | |
| Coopersurgical, INC. | $19.02 | 2022 | |
| Duchesnay USA Incorporated | $18.41 | 2019 | |
| Exeltis, USA INC. | $17.49 | 2020 | |
| Exact Sciences Corporation | $17.24 | 2024 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $16.31 | 2023 | Myfembree |
| Avion Pharmaceuticals | $14.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Jolitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.